MedTrace Logo

Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans

NCT01096550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 319

Last updated 2020-04-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.

Conditions

  • Drug Dependence

Interventions

BEHAVIORAL

Outpatient

Buprenorphine patients receiving 2 to 8 hours of outpatient counseling.

BEHAVIORAL

Intensive Outpatient

Buprenorphine patients receiving 9 or more hours of outpatient counseling.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Friends Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Shannon G Mitchell, PhD · Friends Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096550 on ClinicalTrials.gov